46 related articles for article (PubMed ID: 38695988)
1. Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy.
Fonseca J; Moraes-Fontes MF; Sousa I; Oliveira F; Froes G; Gaivão A; Palmas A; Rebola J; Muresan C; Santos T; Dias D; Varandas M; Lopez-Beltran A; Ribeiro R; Fraga A
J Robot Surg; 2024 May; 18(1):230. PubMed ID: 38809307
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort.
Barayan GA; Majdalany SE; Butaney M; Dalela D; Peabody J; Abdolla F; Menon M; Jeong W
J Endourol; 2024 Jun; 38(6):559-563. PubMed ID: 38429913
[No Abstract] [Full Text] [Related]
3. Retzius-sparing Robot-assisted Simple Prostatectomy: Perioperative and Short-term Functional Outcomes Assessed via Validated Questionnaires.
Novara G; Zattoni F; Parisotto A; Brunetti G; Serbia M; Carletti F; Lami V; Betto G; Zanovello N; Dal Moro F
Eur Urol Open Sci; 2024 Jun; 64():22-29. PubMed ID: 38812921
[TBL] [Abstract][Full Text] [Related]
4. Prostate size ≥ 100 g and its association with long-term outcomes of Retzius-sparing robot-assisted radical prostatectomy.
Maltzman O; Tappero S; Caviglia A; Palagonia E; Buratto C; Chierigo F; Cellini V; Olivero A; Barbieri M; Secco S; Bocciardi AM; Galfano A; Dell'Oglio P
World J Urol; 2024 May; 42(1):283. PubMed ID: 38695988
[TBL] [Abstract][Full Text] [Related]
5. Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step Guide.
Egan J; Marhamati S; Carvalho FLF; Davis M; O'Neill J; Lee H; Lynch JH; Hankins RA; Hu JC; Kowalczyk KJ
Eur Urol; 2021 Jun; 79(6):839-857. PubMed ID: 32536488
[TBL] [Abstract][Full Text] [Related]
6. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis.
Barakat B; Othman H; Gauger U; Wolff I; Hadaschik B; Rehme C
Eur Urol Focus; 2022 Jul; 8(4):1060-1071. PubMed ID: 34429272
[TBL] [Abstract][Full Text] [Related]
7. A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy.
Dalela D; Jeong W; Prasad MA; Sood A; Abdollah F; Diaz M; Karabon P; Sammon J; Jamil M; Baize B; Simone A; Menon M
Eur Urol; 2017 Nov; 72(5):677-685. PubMed ID: 28483330
[TBL] [Abstract][Full Text] [Related]
8. Surgical and functional outcomes of Retzius-sparing robotic-assisted radical prostatectomy versus conventional robotic-assisted radical prostatectomy in patients with biopsy-confirmed prostate cancer. Are outcomes worth it? Systematic review and meta-analysis.
O'Connor-Cordova MA; Macías AGO; Sancen-Herrera JP; Altamirano-Lamarque F; Vargas Del Toro A; Peddinani BK; Canal-Zarate P; O'Connor-Juarez MA
Prostate; 2023 Nov; 83(15):1395-1414. PubMed ID: 37555617
[TBL] [Abstract][Full Text] [Related]
9. Retzius-sparing robot-assisted radical prostatectomy after previous trans-urethral resection of the prostate: Assessment of functional and oncological outcomes.
Tappero S; Vecchio E; Palagonia E; Longoni M; Martiriggiano M; Granelli G; Olivero A; Secco S; Bocciardi AM; Galfano A; Dell'Oglio P
Eur J Surg Oncol; 2023 Aug; 49(8):1524-1535. PubMed ID: 37012110
[TBL] [Abstract][Full Text] [Related]
10. Retzius-sparing Robot-assisted Radical Prostatectomy in High-risk Prostate Cancer Patients: Results from a Large Single-institution Series.
Dell'Oglio P; Tappero S; Longoni M; Buratto C; Scilipoti P; Secco S; Olivero A; Barbieri M; Palagonia E; Napoli G; Strada E; Petralia G; Di Trapani D; Vanzulli A; Bocciardi AM; Galfano A
Eur Urol Open Sci; 2022 Apr; 38():69-78. PubMed ID: 35265866
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Willemse PM; Davis NF; Grivas N; Zattoni F; Lardas M; Briers E; Cumberbatch MG; De Santis M; Dell'Oglio P; Donaldson JF; Fossati N; Gandaglia G; Gillessen S; Grummet JP; Henry AM; Liew M; MacLennan S; Mason MD; Moris L; Plass K; O'Hanlon S; Omar MI; Oprea-Lager DE; Pang KH; Paterson CC; Ploussard G; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TBL
Eur Urol; 2022 Apr; 81(4):337-346. PubMed ID: 34980492
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
